Biomeditsina va amaliyot jurnali, 2022 №2

Тема статьи

COMPARISON STUDYING THE RESULTS OF RADIATION DIAGNOSTICS IN VOLUME LIVER FORMATIONS (225-229)

Авторы

Tursunov Odil, Juraev Mirzhalol, Kuliev Aziz, Raximov Nodir.

Учреждение

Samarkand State Medical Institute Samarkand branch of the Republican Specialized Scientific and Practical Medical Center of Oncology and Radiology

Аннотация

ANNOTATION Purpose: To improve the diagnosis of volumetric formations of the liver using radiation methods. Material and research methods. On the basis of the SВRSSPMCOR, we analyzed the results of PET-CT studies of patients for the period from 2017 to 2020. 67 of them were found to have masses of the liver, there were 36 women (53.73%), and 31 men (46.26%). Research results. Of the 67 patients, 40 (59.70%) had a histologically verified oncological diagnosis at the time of the study. Metabolically active formations were identified in 36 patients. Of these, 33 patients were found to have metastatic liver damage: 3 patients were found to have a combination of metabolically active (metastatic) and metabolically inactive formations (cysts). In the remaining 31 patients, liver lesions had no PET signs of 18F-FDG hypermetabolism. Conclusion: Thus, positron emission tomography turned out to be a highly effective method in detecting liver metastases and their differential diagnosis from benign focal lesions. PET can detect extrahepatic metastases, thereby changing the stage of the disease and allowing to adjust the therapy and tactics of surgical intervention.

Ключевые слова

Key words: liver metastasis, focal formations, positron emission tomography, radiopharmaceutical.

Литературы

1. Adam R. et al. Five–year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal (liver) metastases. Annals of surgical oncology. – 2001. – Vol. 8, № 4. – P. 347–353. 2. Кулиев А.А. Джураев М.Д.Рахимов Н.М.Мелиқулов А.Х. Ошқозон саратони тарқалган шаклида паллиатив жаррохлик даволаш// Биомедицина ва амалиёт журнали | Журнал биомедицины и практики | Journal of biomedicine and practice №4 | 2021. Стр 132-138 3. Caballero T. et al. Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultrastructural study // Histopathology. – 1985. – Vol. 9. – P. 445–456. 4. Cance W.G., Stewart A.K., Menck H.R. The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985– 1996. // Cancer. – 2000. – Vol. 88. – P. 912–920. 5. Greenlee R.T. et al.: Cancer statistics, 2001. CA Cancer J Clin. – 2001. – Vol. 50. – P. 7–33. 6. Little S.A., Fong Y. Hepatocellular carcinoma: current surgical management. //Semin Oncol. – 2001. – Vol. 28. – P. 474–486. 7. Peter E. Valk, Dale L. Bailey, David W. Townsend, Michael N. Maisey. Positron emission tomography: basic science and clinical practice. Springer. – 2003. 8. Mirdjalol Dehkanovich Djuraev, Nodir Maxammatkulovich Rahimov, Mavluda Nigmatovna Karimova,Shakhnoza Shavkatovna Shakhanova Current Views On The Pathogenesis Of The Parietal-Visceral Pathway Of Gastric Cancer Metastasis// The American Journal of Medical Sciences and Pharmaceutical Research (ISSN – 2689-1026) Published: March 31, 2021 9. Арыбжанов Д.Т., Навeсова В.Ш., Маклакова Е.Э., Тасбулатова Г.Е., Сапарбeкова Ж.Д. Опыт рeгионарной химиотeрапии пeрвичного рака пeчени // Сборник матeриалов II рeгиональной конфeрeнции молодых ученых им. Акадeмика РАМН Н.В. Васильева „Актуальные вопросы экспeримeнтальной и клинической онкологии”, 2007 г. 10. Патютко Ю.И., Сагайдак И.В., Чучуев Е.С., Гахраманов А.Д., Иванов А.А. Хирургическое лeчение пeрвичного рака пeчени // Российский мeдицинский журнал: онкология, том 16, № 27. 03 дeкабря 2008 г. 11. Сeмeнов Н.Н. Комбинированное лeчение мeтастазов колорeктального рака в пeчень // Российский мeдицинский журнал: онкология, том 10, № 24. 09 дeкабря 2002 г. 12. Хитрихеев В.Е., Саганов В.П., Ханхараев Н.Х., Дымбрылов Е.В. Рак пeчени: учебное пособие. Улан-Удэ, 2009. 13. Harris N.M., Duffy P.M., Crook T.J. et al. Intravesical pH: a potentially important variable affecting efficacy and the further development of anthracycline chemotherapy for superficial bladder cancer. BJU Int 2019; 90: 957-64. 14. Ziyadullaev Sh.Kh. Rakhimov N. M. Elmamatov O.N. Esankulova B.S. Marker tnfα-308G/A in patients with relative bladder cancer// Oriental Renaissance: Innovative, educational, natural and social sciences. VOLUME 1 |2021 стр 926-932.